ReviewPolymer science & technology (Washington, D.C.)2026
Design and Synthesis of Fluorosurfactants for Microfluidic Droplet-Based Bioapplications.
Review in Polymer science & technology (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surfactants are central to droplet-based microfluidics, where they stabilize immiscible interfaces, prevent coalescence, and enable precise control of discrete fluid volumes for biological and chemical applications. Recent efforts in fluorosurfactant design have emphasized how variations in hydrophilic head groups, fluorinated tail architecture, and synthesis strategies determine performance in droplet systems. This review surveys advances from conventional polyethylene glycol (PEG)-perfluoropolyether (PFPE) architectures to emerging alternatives with nonionic polar head groups, highlighting those with the greatest potential to advance the field. Particular attention is given to reversible addition-fragmentation chain transfer (RAFT) polymerization, which has revolutionized fluorosurfactant development by enabling precise molecular control and tunable properties. This has allowed the integration of responsive functionalities, including temperature-sensitive
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.